Fact Sheet: President Donald J. Trump Announces Second Deal to Bring Most-Favored-Nation Pricing to American Patients
Public Health,Drug Prices,Prescription Drugs,Medicine,Trump Agenda,Medicaid
From the Right
AllSides Media Bias Rating: Lean Right
ADVANCING MOST-FAVORED-NATION PRICING: Today, President Donald J. Trump announced the second agreement with a major pharmaceutical company, AstraZeneca, to bring American drug prices in line with the lowest paid by other developed nations (known as the most-favored-nation, or MFN, price).
The agreement will provide every State Medicaid program in the country access to MFN drug prices on AstraZeneca products, resulting in hundreds of millions of dollars in savings and continuing President Trump’s historic efforts to strengthen the program for the most vulnerable...
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Youth Voices
State Mandates Capping Insulin Costs: A Help or Hindrance?
The Alliance for Civic Engagement
June 15th, 2026
.png.webp)
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
